A Patient with Beta-Propeller Protein-Associated Neurodegeneration: Treatment with Iron Chelation Therapy
Journal of Movement Disorders
;
: 89-92, 2018.
Article
in English
| WPRIM
| ID: wpr-765816
ABSTRACT
We present a case of beta-propeller protein-associated neurodegeneration, a form of neurodegeneration with brain iron accumulation. The patient harbored a novel mutation in the WDR45 gene. A detailed video and description of her clinical condition are provided. Her movement disorder phenomenology was characterized primarily by limb stereotypies and gait dyspraxia. The patient's disability was advanced by the time iron-chelating therapy with deferiprone was initiated, and no clinical response in terms of cognitive function, behavior, speech, or movements were observed after one year of treatment.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Brain
/
Chelation Therapy
/
Cognition
/
Gait Apraxia
/
Extremities
/
Iron
/
Movement Disorders
Type of study:
Qualitative research
Limits:
Humans
Language:
English
Journal:
Journal of Movement Disorders
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS